{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:55:52Z","timestamp":1788382552308,"version":"build-2803163510"},"reference-count":39,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004726","name":"Ministry of Health, British Columbia","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,9,24]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the coverage for the oral cholera vaccine (OCV) campaign conducted during the 2017\/2018 cholera outbreak in Lusaka, Zambia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>A descriptive cross-sectional study employing survey method conducted among 1691 respondents from 369 households following the second round of the 2018 OCV campaign.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study setting<\/jats:title>\n                    <jats:p>Four primary healthcare facilities and their catchment areas in Lusaka city (Kanyama, Chawama, Chipata and Matero subdistricts).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 1691 respondents 12 months and older sampled from 369 households where the campaign was conducted. A satellite map-based sampling technique was used to randomly select households.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data management and analysis<\/jats:title>\n                    <jats:p>\n                      A pretested electronic questionnaire uploaded on an electronic tablet (ODK V.1.12.2) was used for data collection. Descriptive statistics were computed to summarise respondents\u2019 characteristics and OCV coverage per dose. Bivariate analysis (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      test) was conducted to stratify OCV coverage according to age and sex for each round (p&lt;0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall coverage for the first, second and two doses were 81.3% (95% CI 79.24% to 83.36%), 72.1% (95% CI 69.58% to 74.62%) and 66% (95% CI 63.22% to 68.78%), respectively. The drop-out rate was 18.8% (95% CI 14.51% to 23.09%). Of the 81.3% who received the first dose, 58.8% were female. Among those who received the second dose, the majority (61.0%) were females aged between 5 and 14 years (42.6%) and 15 and 35 years (27.7%). Only 15.5% of the participants aged between 36 and 65 and 2.5% among those aged above 65 years received the second dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings confirm the 2018 OCV campaign coverage and highlight the need for follow-up surveys to validate administrative coverage estimates using population-based methods. Reliance on health facility data alone may mask low coverage and prevent measures to improve programming. Future public health interventions should consider sociodemographic factors in order to achieve optimal vaccine coverage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-070796","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:01:12Z","timestamp":1696507272000},"page":"e070796","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Euvichol-plus vaccine campaign coverage during the 2017\/2018 cholera outbreak in Lusaka district, Zambia: a cross-sectional descriptive study"],"prefix":"10.1136","volume":"13","author":[{"given":"Victor M","family":"Mukonka","sequence":"first","affiliation":[{"name":"School of Public Health, Levy Mwanawasa Medical University, Lusaka, Zambia"},{"name":"School of Medicine, The Copperbelt University, Kitwe, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9077-1436","authenticated-orcid":false,"given":"Cephas","family":"Sialubanje","sequence":"additional","affiliation":[{"name":"School of Public Health, Levy Mwanawasa Medical University, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belem Blamwell","family":"Matapo","sequence":"additional","affiliation":[{"name":"Disease Surveillance, World Health Organization, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orbrie","family":"Chewe","sequence":"additional","affiliation":[{"name":"Surveillance and Disease Intelligence, Zambia National Public Health Institute, Lusaka, Zambia"},{"name":"Public Health, Zambia Ministry of Health, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3435-1170","authenticated-orcid":false,"given":"Albertina Moraes","family":"Ngomah","sequence":"additional","affiliation":[{"name":"Communication Information & Research, Zambia National Public Health Institute, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willaim","family":"Ngosa","sequence":"additional","affiliation":[{"name":"Communication Information & Research, Zambia National Public Health Institute, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Hamoonga","sequence":"additional","affiliation":[{"name":"Surveillance and Disease Intelligence, Zambia National Public Health Institute, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyambe","family":"Sinyange","sequence":"additional","affiliation":[{"name":"Surveillance and Disease Intelligence, Zambia National Public Health Institute, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Mzyece","sequence":"additional","affiliation":[{"name":"Surveillance and Disease Intelligence, Zambia National Public Health Institute, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Mazyanga","sequence":"additional","affiliation":[{"name":"Communication Information & Research, Zambia National Public Health Institute, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Bakyaita","sequence":"additional","affiliation":[{"name":"World Health Organization, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Kapata","sequence":"additional","affiliation":[{"name":"Epidemic Preparedness and Response, Zambia National Public Health Institute, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2025121411333024000_13.10.e070796.1","doi-asserted-by":"publisher","DOI":"10.1007\/82_2014_363"},{"key":"2025121411333024000_13.10.e070796.2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01286-11"},{"key":"2025121411333024000_13.10.e070796.3","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.vaccine.2019.07.078","article-title":"Epidemiology of cholera","volume":"38 Suppl 1","author":"Deen","year":"2020","journal-title":"Vaccine"},{"key":"2025121411333024000_13.10.e070796.4","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-12-287","article-title":"Cholera risk factors, Papua New Guinea, 2010","volume":"12","author":"Rosewell","year":"2012","journal-title":"BMC Infect Dis"},{"key":"2025121411333024000_13.10.e070796.5","unstructured":"WHO . Cholera. 2022. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cholera"},{"key":"2025121411333024000_13.10.e070796.6","unstructured":"CDC . About global cholera. about global cholera. 2022. Available: cdc.gov"},{"key":"2025121411333024000_13.10.e070796.7","unstructured":"CDC . Data and statistics on global cholera, data and statistics on global cholera. 2023. Available: cdc.gov"},{"key":"2025121411333024000_13.10.e070796.8","unstructured":"WHO . WHO consultation on oral cholera vaccine (OCV) stockpile strategic framework: potential objectives and possible policy options. 2023. Available: www.who.int\/vaccines-documents"},{"key":"2025121411333024000_13.10.e070796.9","doi-asserted-by":"publisher","DOI":"10.1177\/2051013614537819"},{"key":"2025121411333024000_13.10.e070796.10","unstructured":"WHA . Stop Cholera. Available at: The 64th World Health Assembly Resolution for Renewed Efforts to Prevent and Control Cholera (May 2011) | DOVE: Stop Cholera. 2011."},{"key":"2025121411333024000_13.10.e070796.11","unstructured":"WHO . n.d. Cholera vaccine. available at: immunization, vaccines and BIOLOGICALS. Available: who.int"},{"key":"2025121411333024000_13.10.e070796.12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Oral cholera vaccine working group of the global task force on cholera control. protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"10","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025121411333024000_13.10.e070796.13","doi-asserted-by":"crossref","first-page":"e1028","DOI":"10.1016\/S2214-109X(18)30284-5","article-title":"Long-term effectiveness of one and two doses of a killed, Bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study","volume":"6","author":"Franke","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2025121411333024000_13.10.e070796.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.025"},{"key":"2025121411333024000_13.10.e070796.15","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.vaccine.2015.03.073","article-title":"Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha state, India","volume":"33","author":"Wierzba","year":"2015","journal-title":"Vaccine"},{"key":"2025121411333024000_13.10.e070796.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099381","article-title":"Safety and Immunogenicity of a live oral recombinant cholera vaccine Va1.4: a randomized, placebo controlled trial in healthy adults in a cholera Endemic area in Kolkata, India","volume":"9","author":"Kanungo","year":"2014","journal-title":"PLoS One"},{"key":"2025121411333024000_13.10.e070796.17","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two Bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"2025121411333024000_13.10.e070796.18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2471\/BLT.16.189241","article-title":"Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia","volume":"96","author":"Poncin","year":"2018","journal-title":"Bull World Health Organ"},{"key":"2025121411333024000_13.10.e070796.19","unstructured":"WHO . African region. Disease outbreak - cholera - Zambia - 11 December 2017 | WHO | regional office for Africa. 2017."},{"key":"2025121411333024000_13.10.e070796.20","unstructured":"WHO . Mass cholera vaccination campaign launched, mass cholera vaccination campaign launched (who.INT), accessed on 8th August, 2023. 2021."},{"key":"2025121411333024000_13.10.e070796.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066945","article-title":"Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017\/2018 outbreak: a matched case\u2013control study in Lusaka, Zambia","volume":"12","author":"Sialubanje","year":"2022","journal-title":"BMJ Open"},{"key":"2025121411333024000_13.10.e070796.22","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1177\/1049732318794207","article-title":"Exploring the perceived effectiveness of applied theater as a maternal health promotion tool in rural Zambia","volume":"28","author":"Massar","year":"2018","journal-title":"Qual Health Res"},{"key":"2025121411333024000_13.10.e070796.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057589","article-title":"Perspectives on factors influencing transmission of COVID-19 in Zambia: a qualitative study of health workers and community members","volume":"12","author":"Sialubanje","year":"2022","journal-title":"BMJ Open"},{"key":"2025121411333024000_13.10.e070796.24","unstructured":"Central Statistics Office, Ministry of Health and ICF International . Zambia Demographic and Health Survey 2013-14. Rockville, Maryland, 2014."},{"key":"2025121411333024000_13.10.e070796.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198592","article-title":"Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique","volume":"13","author":"Sem\u00e1 Baltazar","year":"2018","journal-title":"PLoS ONE"},{"key":"2025121411333024000_13.10.e070796.26","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1016\/j.vaccine.2016.09.067","article-title":"Monitoring vaccination coverage: defining the role of surveys","volume":"34","author":"Cutts","year":"2016","journal-title":"Vaccine"},{"key":"2025121411333024000_13.10.e070796.27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tmi.12883","article-title":"Comparison of administrative and survey data for estimating vitamin A supplementation and Deworming coverage of children under five years of age in sub-Saharan Africa","volume":"22","author":"Janmohamed","year":"2017","journal-title":"Trop Med Int Health"},{"key":"2025121411333024000_13.10.e070796.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038464","article-title":"Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda","volume":"10","author":"Bwire","year":"2020","journal-title":"BMJ Open"},{"key":"2025121411333024000_13.10.e070796.29","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1016\/j.vaccine.2017.07.104","article-title":"Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass campaigns, Malawi, 2016","volume":"35","author":"Sauvageot","year":"2017","journal-title":"Vaccine"},{"key":"2025121411333024000_13.10.e070796.30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3201\/eid2301.160881","article-title":"Oral cholera vaccine coverage during an outbreak and humanitarian crisis, Iraq, 2017","volume":"23","author":"Lam","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2025121411333024000_13.10.e070796.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002465","article-title":"First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, guinea, 2012","volume":"7","author":"Luquero","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121411333024000_13.10.e070796.32","unstructured":"WHO . Preventing and controlling cholera in Endemic countries. available at: preventing and controlling cholera in Endemic countries (who.INT). 2022."},{"key":"2025121411333024000_13.10.e070796.33","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/S2214-109X(16)00037-1","article-title":"A second affordable oral cholera vaccine: implications for the global vaccine stockpile","volume":"4","author":"Desai","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2025121411333024000_13.10.e070796.34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2471\/BLT.15.166892","article-title":"A retrospective analysis of oral cholera vaccine use, disease severity and deaths during an outbreak in South Sudan","volume":"94","author":"Bekolo","year":"2016","journal-title":"Bull World Health Organ"},{"key":"2025121411333024000_13.10.e070796.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053585","article-title":"Pre-Emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba district, Niassa province, Mozambique: feasibility, vaccination coverage and delivery costs using Choltool","volume":"12","author":"Elias Chitio","year":"2022","journal-title":"BMJ Open"},{"key":"2025121411333024000_13.10.e070796.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.042"},{"key":"2025121411333024000_13.10.e070796.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058028","article-title":"Perspectives on the COVID-19 vaccine uptake: a qualitative study of community members and health workers in Zambia","volume":"12","author":"Sialubanje","year":"2022","journal-title":"BMJ Open"},{"key":"2025121411333024000_13.10.e070796.38","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1016\/j.vaccine.2019.09.018","article-title":"Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014","volume":"37","author":"Burnett","year":"2019","journal-title":"Vaccine"},{"key":"2025121411333024000_13.10.e070796.39","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.109-5021"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-070796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T19:33:42Z","timestamp":1765740822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-070796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,5]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjopen-2022-070796"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-070796","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}